BRIEF published on 12/13/2024 at 12:02, 11 months 23 days ago Citigroup réduit sa participation dans GENEURO SA Euronext Paris Franchissement De Seuil Vente D'actions GeNeuro SA Citigroup
BRIEF published on 12/13/2024 at 12:02, 11 months 23 days ago Citigroup reduces its stake in GENEURO SA Euronext Paris Sale Of Shares Threshold Crossing GeNeuro SA Citigroup
PRESS RELEASE published on 12/13/2024 at 11:57, 11 months 23 days ago Franchissement de seuils Déclaration de franchissement de seuils de Citigroup Global Markets Limited concernant GENEURO SA publiée le 12 décembre 2024 Déclaration Franchissement De Seuils GeNeuro SA Citigroup Global Markets Limited
BRIEF published on 12/06/2024 at 18:35, 11 months 29 days ago GeNeuro dévoile son nouveau médicament de précision pour la SLA Médecine De Précision GeNeuro Traitement De La SLA GNK-301 ENVIRONNEMENT HERV-K
BRIEF published on 12/06/2024 at 18:35, 11 months 29 days ago GeNeuro's New Precision Medicine for ALS Unveiled Precision Medicine GeNeuro ALS Treatment GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 11 months 29 days ago Informations privilégiées / Autres communiqués Nouvelle approche de médecine de précision pour la SLA avec GNK-301 de GeNeuro présentée au 35e Symposium international sur la SLA/MMN Recherche Médecine De Précision GeNeuro SLA GNK-301
PRESS RELEASE published on 12/06/2024 at 18:30, 11 months 29 days ago Inside Information / Other news releases GeNeuro presents groundbreaking findings on precision medicine for ALS patients with GNK-301 at the 35th International Symposium on ALS/MND. Research highlights potential of targeting HERV-K ENV to transform ALS treatment Precision Medicine ALS GeNeuro GNK-301 HERV-K ENV
BRIEF published on 11/06/2024 at 09:48, 1 year ago Crossing of thresholds by Invus Public Equities in GENEURO SA Euronext Paris Capital Increase Crossing Thresholds GeNeuro SA Invus Public Equities
BRIEF published on 11/06/2024 at 09:48, 1 year ago Franchissement de seuils par Invus Public Equities dans GENEURO SA Euronext Paris Augmentation De Capital Franchissement De Seuils GeNeuro SA Invus Public Equities
PRESS RELEASE published on 11/06/2024 at 09:43, 1 year ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities, LP. concernant GENEURO SA sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuils GeNeuro SA Invus Public Equities
Published on 12/05/2025 at 02:35, 10 hours 14 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 49 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 44 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 49 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 43 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 49 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 49 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 34 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 11:08, 1 hour 40 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 08:45, 4 hours 4 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 4 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 6 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 34 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 18 hours 49 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
